Alterations in the CXCL12/CXCR7 axis can influence tumor cell invasion and adhesion processes in prostate cancer, increasing the expression of CD44, and niche factors like VEGF, which suggests a role for CXCR7 in the CSC niche [168]. Here, CD44 is linked to neoplasm.